1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-(6-hydroxypyridazin-3-yl)-1H-pyrazol-3-yl)urea

ID: ALA2207436

Chembl Id: CHEMBL2207436

PubChem CID: 71459746

Max Phase: Preclinical

Molecular Formula: C22H24N8O2

Molecular Weight: 432.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(-c3ccc(O)nn3)[nH]n2)cc1

Standard InChI:  InChI=1S/C22H24N8O2/c1-13-5-7-14(8-6-13)30-19(12-17(29-30)22(2,3)4)24-21(32)23-18-11-16(26-27-18)15-9-10-20(31)28-25-15/h5-12H,1-4H3,(H,28,31)(H3,23,24,26,27,32)

Standard InChI Key:  PLFCRBVMONXFRP-UHFFFAOYSA-N

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTK2B Tclin Protein tyrosine kinase 2 beta (2827 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ptk2b Protein-tyrosine kinase 2-beta (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 432.49Molecular Weight (Monoisotopic): 432.2022AlogP: 4.01#Rotatable Bonds: 4
Polar Surface Area: 133.64Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 8.37CX Basic pKa: 1.96CX LogP: 4.68CX LogD: 4.64
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.38Np Likeness Score: -2.04

References

1. Bhattacharya SK, Aspnes GE, Bagley SW, Boehm M, Brosius AD, Buckbinder L, Chang JS, Dibrino J, Eng H, Frederick KS, Griffith DA, Griffor MC, Guimarães CR, Guzman-Perez A, Han S, Kalgutkar AS, Klug-McLeod J, Garcia-Irizarry C, Li J, Lippa B, Price DA, Southers JA, Walker DP, Wei L, Xiao J, Zawistoski MP, Zhao X..  (2012)  Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors.,  22  (24): [PMID:23153798] [10.1016/j.bmcl.2012.10.039]

Source